Walvax Biotechnology Co., Ltd. (SHE:300142)
China flag China · Delayed Price · Currency is CNY
10.09
-0.06 (-0.59%)
Apr 25, 2025, 2:45 PM CST

Walvax Biotechnology Income Statement

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2015 - 2019
Period Ending
Dec '24 Dec '23 Jan '23 Jan '22 Dec '20 2015 - 2019
Operating Revenue
2,8044,1065,0793,4522,927
Upgrade
Other Revenue
17.867.927.6510.511.62
Upgrade
Revenue
2,8214,1145,0863,4632,939
Upgrade
Revenue Growth (YoY)
-31.41%-19.12%46.89%17.82%162.13%
Upgrade
Cost of Revenue
742.2750.76673.14403.54404.53
Upgrade
Gross Profit
2,0793,3634,4133,0592,534
Upgrade
Selling, General & Admin
1,3991,8162,3021,6361,352
Upgrade
Research & Development
596.54776.43922.25616.36173.78
Upgrade
Other Operating Expenses
-4.12-10016.4819.83-8.34
Upgrade
Operating Expenses
2,0552,5323,2392,2671,511
Upgrade
Operating Income
24.01831.051,174792.221,024
Upgrade
Interest Expense
-8.43-5.95-7.11-5.77-0.6
Upgrade
Interest & Investment Income
66.7581.3581.82103.2942.83
Upgrade
Currency Exchange Gain (Loss)
4.053.060.82-0.22-4.65
Upgrade
Other Non Operating Income (Expenses)
80.95-63.64-75.3933.8839.57
Upgrade
EBT Excluding Unusual Items
167.33845.861,174923.41,101
Upgrade
Gain (Loss) on Sale of Investments
-98.34-234.75-199.33-280.74279.89
Upgrade
Gain (Loss) on Sale of Assets
-1.77-0.83-0.380.23-1.08
Upgrade
Asset Writedown
-7.68-11.31-1.66-5.11-6.6
Upgrade
Other Unusual Items
124.96-97.871.15-
Upgrade
Pretax Income
184.5598.981,070708.951,373
Upgrade
Income Tax Expense
10.187.65132.24107.59162.12
Upgrade
Earnings From Continuing Operations
174.4511.33938.23601.351,211
Upgrade
Net Income to Company
174.4511.33938.23601.351,211
Upgrade
Minority Interest in Earnings
-32.24-91.93-209.57-173.6-208
Upgrade
Net Income
142.16419.39728.65427.751,003
Upgrade
Net Income to Common
142.16419.39728.65427.751,003
Upgrade
Net Income Growth
-66.10%-42.44%70.35%-57.36%606.60%
Upgrade
Shares Outstanding (Basic)
1,5991,6001,6031,5691,539
Upgrade
Shares Outstanding (Diluted)
1,5991,6001,6041,5731,559
Upgrade
Shares Change (YoY)
-0.06%-0.21%1.93%0.90%1.37%
Upgrade
EPS (Basic)
0.090.260.450.270.65
Upgrade
EPS (Diluted)
0.090.260.450.270.64
Upgrade
EPS Growth
-66.08%-42.32%67.12%-57.74%597.07%
Upgrade
Free Cash Flow
486.49188.25110.31-398.21-292.94
Upgrade
Free Cash Flow Per Share
0.300.120.07-0.25-0.19
Upgrade
Dividend Per Share
0.0100.0100.0100.0270.070
Upgrade
Dividend Growth
---62.96%-61.43%-
Upgrade
Gross Margin
73.69%81.75%86.77%88.35%86.24%
Upgrade
Operating Margin
0.85%20.20%23.08%22.88%34.84%
Upgrade
Profit Margin
5.04%10.20%14.32%12.35%34.13%
Upgrade
Free Cash Flow Margin
17.24%4.58%2.17%-11.50%-9.97%
Upgrade
EBITDA
387.611,1211,422927.651,148
Upgrade
EBITDA Margin
13.74%27.25%27.96%26.79%39.06%
Upgrade
D&A For EBITDA
363.59289.97248.4135.43123.95
Upgrade
EBIT
24.01831.051,174792.221,024
Upgrade
EBIT Margin
0.85%20.20%23.08%22.88%34.84%
Upgrade
Effective Tax Rate
5.48%14.63%12.35%15.18%11.80%
Upgrade
Revenue as Reported
2,8214,1145,086--
Upgrade
Advertising Expenses
42.6678.0194.8324.1520.85
Upgrade
Source: S&P Global Market Intelligence. Standard template. Financial Sources.